| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1–AXL signal relay in liver cancer cells
|
Tanaka, Toshimitsu
|
|
|
18 |
3 |
p. 984-997
|
artikel
|
| 2 |
APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
|
Maiwall, Rakhi
|
|
|
18 |
3 |
p. 833-869
|
artikel
|
| 3 |
Are dairy products the answer to metabolic dysfunction-associated fatty liver disease?
|
Lau, Kristopher Cho-Hei
|
|
|
18 |
3 |
p. 870-872
|
artikel
|
| 4 |
Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation
|
Feng, Shu
|
|
|
18 |
3 |
p. 1040-1052
|
artikel
|
| 5 |
Correction to: Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease
|
Nagayama, Itsuo
|
|
|
18 |
3 |
p. 1067-1069
|
artikel
|
| 6 |
Correction to: Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma
|
Xu, Ying
|
|
|
18 |
3 |
p. 1064
|
artikel
|
| 7 |
Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines
|
Teng, Wei
|
|
|
18 |
3 |
p. 1066
|
artikel
|
| 8 |
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
|
Wang, Jitao
|
|
|
18 |
3 |
p. 1062-1063
|
artikel
|
| 9 |
Correction to: Targeting ferroptosis in hepatocellular carcinoma
|
Mo, Yuqian
|
|
|
18 |
3 |
p. 1065
|
artikel
|
| 10 |
“Dosis sola facit venenum”—Evidence for causality in the association between ketamine and cholestatic liver injury
|
Wendel-Garcia, Pedro David
|
|
|
18 |
3 |
p. 1056-1057
|
artikel
|
| 11 |
Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH)
|
Büyük, Melek
|
|
|
18 |
3 |
p. 1011-1019
|
artikel
|
| 12 |
Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections
|
Chen, Tao
|
|
|
18 |
3 |
p. 817-832
|
artikel
|
| 13 |
FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence
|
Simbrunner, Benedikt
|
|
|
18 |
3 |
p. 929-942
|
artikel
|
| 14 |
Global burden and trends of acute viral hepatitis among children and adolescents from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019
|
Xiao, Wanglong
|
|
|
18 |
3 |
p. 917-928
|
artikel
|
| 15 |
Gut-microbiome composition and function in progression of alcohol-associated liver disease: going beyond western experiences
|
Kanagalingam, Gowthami
|
|
|
18 |
3 |
p. 873-875
|
artikel
|
| 16 |
Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma
|
Ayada, Ibrahim
|
|
|
18 |
3 |
p. 1053-1055
|
artikel
|
| 17 |
Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed
|
Yang, Shiye
|
|
|
18 |
3 |
p. 1058-1059
|
artikel
|
| 18 |
Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studies
|
Chen, Wen
|
|
|
18 |
3 |
p. 998-1010
|
artikel
|
| 19 |
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease
|
Wang, Shao-Wen
|
|
|
18 |
3 |
p. 943-951
|
artikel
|
| 20 |
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments
|
Chen, Shuyan
|
|
|
18 |
3 |
p. 904-916
|
artikel
|
| 21 |
MAFLD identifies patients with significant hepatic fibrosis better than MASLD
|
Pan, Ziyan
|
|
|
18 |
3 |
p. 964-972
|
artikel
|
| 22 |
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma
|
Kim, Hyung-Don
|
|
|
18 |
3 |
p. 973-983
|
artikel
|
| 23 |
Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis
|
Jiang, Shaowen
|
|
|
18 |
3 |
p. 892-903
|
artikel
|
| 24 |
Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases
|
Liu, Ming
|
|
|
18 |
3 |
p. 1029-1039
|
artikel
|
| 25 |
Surgical risk stratification in patients with cirrhosis
|
Ostojic, Ana
|
|
|
18 |
3 |
p. 876-891
|
artikel
|
| 26 |
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes
|
Ma, Xiaoyan
|
|
|
18 |
3 |
p. 952-963
|
artikel
|
| 27 |
The safety profile of endoscopic variceal ligation in patients with esophageal varices
|
Krige, Jake E.
|
|
|
18 |
3 |
p. 1060-1061
|
artikel
|
| 28 |
Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography
|
He, Ruiling
|
|
|
18 |
3 |
p. 1020-1028
|
artikel
|
Tijdschrift beschrijving